Pharma Marketers: FDA Taking Too Long Developing Social Media Guidelines
The FDA held public hearings just last week to discuss establishing guidelines for pharmaceutical marketers operating in the new world of social media. Already some are complaining that the process is taking too long.
“Does the FDA get it?” If it did, “they wouldn’t be having this meeting now, many, many months after it was already apparent how quickly Web communications is changing,” Mark Senak, author of the blog Eye on FDA and a senior vice-president at Fleishman-Hillard told
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in